home.aspx
 
EVENTS

Applying behavioural interventions in chronic diseases
APPLYING BEHAVIOURAL INTERVENTIONS IN CHRONIC DISEASES
February 06-06, 2020
Chronic diseases are the leading cause of death and disability worldwide and have a staggering impact on patients’ lives and the provision of healthcare around the world. Tackling conditions such as diabetes, heart disease and stroke is of vital importance if patient outcomes are to be improve...

ALK

SHARESHARESHARE
ALK is a research-driven, global pharmaceutical company focusing on allergy prevention, diagnosis and treatment. We are the foremost innovators in allergy immunotherapy – a unique treatment which reduces allergic symptoms and treats the cause of the allergy.
SHARESHARESHARE

RELATED NEWS


95Visual is pleased to announce the launch of Blue River Pharmacy’s new website. The primary goal during the process was to improve the navigation of Blue River’s vast product offering. Specifically, Blue River wanted an exceptionally organized website with easy-to-read text for all patients and customers. The features Blue River chose to include in the redesign now make finding products a breeze. Customers will love how Blue River goes above and beyond to ensure they provide the bes...

READ MORE

In the year ahead, health care promises to be a central issue in the 2020 election. According to a report issued this week at the 2o19 American Society of Health System Pharmacists Midyear Clinical Meeting & Exposition  from McKesson RxO, which detailed the major trends and challenges in health care ahead, the increasing complexity of integrated delivery networks and a need for more technology and associated analytics were highlighted as major areas of focus in the year ahead and in fut...

READ MORE

The US Food and Drug Administration (FDA) has approved Biogen and Alkermes’ oral drug Vumerity (diroximel fumarate) to treat relapsing forms of multiple sclerosis (MS). Biogen holds the exclusive licence to commercialise the drug globally and intends to make it available in the US in the coming days. Biogen chief medical officer and research and development executive vice-president Alfred Sandrock said: “The FDA’s approval of Vumerity delivers on Biogen’s commitment to pu...

READ MORE

After more than 2,600 lawsuits nationwide involving their role in the opioid epidemic sweeping through the country, Purdue Pharma — the manufacturer of prescription painkiller OxyContin — filed for bankruptcy Sept. 16. In 2017, opioids were responsible for 47,600 of the 70,237 U.S. drug overdose deaths — with more than 28,000 of these opioid-related deaths being attributed to synthetic opioids, such as fentanyl. From 1999 to 2017, more than 400,000 Americans have died from opio...

READ MORE

The pharmaceutical companies have been acquiring new assets and subsidiaries in order to take over their research and intellectual property this has become a growing trend in the pharmaceutical world. Here’s a look at some new acquisitions in pharma. Alkem Laboratories Limited informed the markets on Friday that the company has acquired an new undertaking, as a whole and on a going and running concern basis from Cachet Pharmaceuticals Private Limited, who is a subsidiary of the company. Th...

READ MORE

Expensive medicines are a growing problem the world over and for too long big pharma has been able to charge extortionate prices, leaving patients struggling to access the treatment they need. The plight of Luis Walker, the 9-year old boy with cystic fibrosis featured in Jeremy Corbyn’s speech at the Labour party conference yesterday, illustrates how fundamentally broken our system of developing medicines is and why proposals to protect public health and take on the power of pharmaceutical...

READ MORE

The trade conflict with China seems to escalate, although it can change with a tweet. The first of two rounds of tariffs on billions of dollars’ worth of Chinese goods is now in effect, even as the final positioning or even talk of deals and delays are in flux. These tariffs have implications for pharmaceutical companies’ supply chain planning for active pharmaceutical ingredients (APIs), the components of drugs that produce their therapeutic effects. Tariffs on APIs imported from Ch...

READ MORE

Pharma watchers have been awaiting House Speaker Nancy Pelosi’s drug pricing plan, and on Monday the industry got a peek at what Democrats are discussing to lower drug prices. The upshot? If the House leadership gets its way, it would devastate pharma's pricing power. The leaked document is outdated and the proposals could change, a senior aide told The Hill. The industry would put up fierce opposition, and Republicans could well balk, too. But the bullet points offer a glimpse into th...

READ MORE

In the heat of the most ferocious battle over drug prices in years, pharmaceutical companies are showering U.S. senators with campaign cash as sweeping legislation heads toward the floor. A new Kaiser Health News database tracks campaign donations from drugmakers over the past 10 years. In the first six months of this year alone, political action committees run by employees of drug companies and their trade groups have given the 30 senators expected to run for reelection nearly $845,000, the lat...

READ MORE

FibroGen has not even filed its AstraZeneca-partnered oral anemia drug roxadustat for U.S. approval. But the collaborators have already scored their second nod for the blockbuster hopeful in China. Last December, the pair made a rare if not only case out of roxadustat by racking up its first-in-class approval in China before any other country. At that time, Chinese authorities greenlighted the drug for patients on dialysis. With this second approval, it’s now allowed to treat the larger no...

READ MORE

EVENTS

Applying behavioural interventions in chronic diseases
APPLYING BEHAVIOURAL INTERVENTIONS IN CHRONIC DISEASES
February 06-06, 2020
Chronic diseases are the leading cause of death and disability worldwide and have a staggering impact on patients’ lives and the provision of healthcare around the world. Tackling conditions such as diabetes, heart disease and stroke is of vital importance if patient outcomes are to be improve...